← Back to headlines
Pfizer Raises 2026 Guidance Despite COVID-19 Sales Decline
Pfizer has managed to raise its 2026 financial guidance, overcoming a tumble in sales related to its COVID-19 products.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
South Korea Central Bank Raises Interest Rates for Second Consecutive Meeting
13m ago
Bank of Korea Raises Interest Rate to 3 Percent Amid Growth Upgrade
28m ago
Nvidia in Talks to Acquire AI Platform Hugging Face for Over $13 Billion
40m ago
Meta Reaches Up to $18 Billion Settlement in Teen Social Media Addiction Lawsuit
43m ago